Search research articles
Contact Us
Filters
Showing results (81-90 of 226) with videos related to
Page
of 23
Sort By:
European Journal of Immunology
|
January 27, 2012
IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1
Inessa Schwab, Markus Biburger, Gerhard Krönke, et al.
The Journal of Experimental Medicine
|
March 8, 2006
Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors
Yoshikatsu Kaneko, Falk Nimmerjahn, Michael P Madaio, et al.
The Journal of Experimental Medicine
|
March 8, 2006
Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy
Yasuhito Hamaguchi, Yan Xiu, Kazuhiro Komura, et al.
STAR Protocols
|
April 18, 2022
Determining immunoglobulin-specific B cell receptor repertoire of murine splenocytes by next-generation sequencing
Anja Werner, Simon Schäfer, Nina Gleußner, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 26, 2008
In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner
Heike Albert, Mattias Collin, Diana Dudziak, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
September 18, 2015
Deregulated Fcγ receptor expression in patients with CIDP
Isaak Quast, Flavio Cueni, Falk Nimmerjahn, et al.
European Journal of Immunology
|
August 4, 2017
IgG subclass and vaccination stimulus determine changes in antigen specific antibody glycosylation in mice
Daniela Kao, Anja Lux, Anja Schaffert, et al.
European Journal of Immunology
|
September 5, 2012
B cells and CD22 are dispensable for the immediate antiinflammatory activity of intravenous immunoglobulins in vivo
Inessa Schwab, Michaela Seeling, Markus Biburger, et al.
European Journal of Immunology
|
June 11, 2013
Nucleoprotein-specific nonneutralizing antibodies speed up LCMV elimination independently of complement and FcγR
Tobias Straub, Oliver Schweier, Michael Bruns, et al.
Expert Review of Clinical Immunology
|
March 7, 2012
FcγRIIB: a modulator of cell activation and humoral tolerance
Birgit Lehmann, Inessa Schwab, Sybille Böhm, et al.
Page
of 23
Search research articles
Search
Showing results (81-90 of 226) with videos related to
Sort By:
Page
of 23
European Journal of Immunology
|
January 27, 2012
IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1
Inessa Schwab, Markus Biburger, Gerhard Krönke, et al.
The Journal of Experimental Medicine
|
March 8, 2006
Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors
Yoshikatsu Kaneko, Falk Nimmerjahn, Michael P Madaio, et al.
The Journal of Experimental Medicine
|
March 8, 2006
Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy
Yasuhito Hamaguchi, Yan Xiu, Kazuhiro Komura, et al.
STAR Protocols
|
April 18, 2022
Determining immunoglobulin-specific B cell receptor repertoire of murine splenocytes by next-generation sequencing
Anja Werner, Simon Schäfer, Nina Gleußner, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 26, 2008
In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner
Heike Albert, Mattias Collin, Diana Dudziak, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
September 18, 2015
Deregulated Fcγ receptor expression in patients with CIDP
Isaak Quast, Flavio Cueni, Falk Nimmerjahn, et al.
European Journal of Immunology
|
August 4, 2017
IgG subclass and vaccination stimulus determine changes in antigen specific antibody glycosylation in mice
Daniela Kao, Anja Lux, Anja Schaffert, et al.
European Journal of Immunology
|
September 5, 2012
B cells and CD22 are dispensable for the immediate antiinflammatory activity of intravenous immunoglobulins in vivo
Inessa Schwab, Michaela Seeling, Markus Biburger, et al.
European Journal of Immunology
|
June 11, 2013
Nucleoprotein-specific nonneutralizing antibodies speed up LCMV elimination independently of complement and FcγR
Tobias Straub, Oliver Schweier, Michael Bruns, et al.
Expert Review of Clinical Immunology
|
March 7, 2012
FcγRIIB: a modulator of cell activation and humoral tolerance
Birgit Lehmann, Inessa Schwab, Sybille Böhm, et al.
Page
of 23